Sofwave vs Ultherapy vs Thermage: Which Lifting Device Fits Your Skin?

Key Points: Choosing between Sofwave, Ultherapy, and Thermage comes down to which skin layer your face actually needs to target — not which device sounds most impressive. This guide breaks down two evidence-based combination approaches using published clinical data, so you can walk into a consultation already knowing what questions to ask.

Why There's No Single 'Best' Lifting Device

One of the most common questions that comes up in lifting consultations is: *'Should I get Sofwave or Ultherapy?'* Honestly, there's no single right answer — and that's not a cop-out. Lifting devices are fundamentally tools that deliver heat to different depths of the face, and the depth they reach determines the type of change you can realistically expect.

Think of it this way: if your concern is surface-level elasticity loss and fine texture issues, targeting the deep fascial layer (SMAS) might actually overshoot the problem. On the other hand, if your cheeks are visibly descending and your jawline is blurring, working only in the mid-dermis may not be enough to make a meaningful difference.

So instead of asking 'which device is best,' the more useful question is: 'Which layer does my face need right now?' That's the framework this article is built around — and it's backed by published clinical data, not just clinical impression.

Sofwave vs Ultherapy: How Deep Does Each Device Actually Go?

Sofwave delivers synchronous ultrasound energy uniformly to the mid-dermis at approximately 1.5 mm depth. This is quite different from Ultherapy, which focuses energy into discrete thermal coagulation points at depths of up to 4.5 mm — reaching the SMAS (superficial musculoaponeurotic system) fascial layer. Even though both are classified as 'ultrasound-based' devices, what they do inside the skin is quite distinct.

A histological study published in the *Journal of Cosmetic Dermatology* (Suh DH et al., 2025) confirmed that Sofwave treatment led to measurable increases in both collagen density and elastic fiber organization within the mid-dermis at 2 months post-treatment. On collagen-specific staining, the mid-dermis appeared visibly denser after treatment. On elastic fiber staining, previously fragmented fibers were replaced by more continuous, upright fibers.

Ultherapy, by contrast, creates focal thermal injury points at depth — the asterisk-marked spots visible in tissue cross-section images from the clinical literature (Marquardt K et al., *J Cosmet Dermatol*, 2025). The surrounding tissue remains intact while targeted heat zones trigger a remodeling response deep in the fascial layer. In the FDA pivotal trial (ULT-302 protocol, n=70, submental/neck region), quantitative imaging showed a tissue lift response rate of approximately 73% at 90 days, with 67% of patients self-reporting perceived improvement.

Sofwave vs Ultherapy: Key Differences at a Glance

Sofwave + Thermage FLX: Who Is This Combination For?

This pairing tends to work well for people in their early-to-mid 30s whose primary concern is skin texture, fine lines, and subtle firmness loss — rather than significant gravitational sagging. Both Sofwave and Thermage FLX operate within the dermal layers and do not reach the fascial plane, which means the treatment profile is gentler overall.

In a multicenter clinical study (Wang JV et al., *Dermatology Surgery*, 2021), Sofwave monotherapy showed wrinkle scale improvement of 1–3 grades in approximately 86% of subjects at 12 weeks, with an investigator global assessment improvement rate of 88%. Patient self-reported satisfaction came in at around 72% — slightly lower than investigator ratings, which is worth noting because it reflects the realistic perception gap that can exist between objective measurement and what the patient feels.

Because neither device targets the SMAS, bruising, swelling, and volume-related side effects are considerably less likely than with deeper treatments. The tradeoff is that the result feels more like 'gradually firming up' than 'visibly lifted.' For those who want subtle, low-downtime improvement with a good safety margin, this combination can be a reasonable starting point — but it's important to go in with calibrated expectations.

One important clarification: the improvement rates cited above are from Sofwave monotherapy trials. There is currently no large-scale controlled study directly validating the combined effect of Sofwave + Thermage FLX, so these numbers should not be assumed to multiply or add together.

💡 Sofwave + Thermage FLX = dermal-layer refinement, not fascial lifting. Great for early-stage laxity; not designed to reverse significant gravitational sagging.

Ultherapy vs Thermage vs Sofwave: Lifting Mechanisms Compared

Sofwave + Ultherapy + PRF: Who Needs This Combination?

If you're noticing heavier cheek descent, a softened jawline, or the feeling that your face is 'sliding downward' when you look in the mirror — targeting only the dermis may not be sufficient to address the underlying structural change. This is where adding Ultherapy to the protocol can make a meaningful difference, because it physically contracts the SMAS fascial layer, creating a more structural lifting effect.

The role of Sofwave in this combination is complementary: while Ultherapy works at depth, Sofwave addresses the overlying dermis simultaneously — so both the structural support and the surface quality are targeted in the same session. This layered approach is based on the principle that true facial descent is a multi-layer problem that rarely has a single-layer solution.

PRF (Platelet-Rich Fibrin, derived from the patient's own blood) is sometimes added to this protocol to support tissue recovery after the thermal stimulation from both devices. The idea is that growth factors concentrated in PRF may help the thermally stressed tissue heal more smoothly and efficiently — though it's worth being transparent: direct large-scale comparative studies on this specific three-way combination do not yet exist. The rationale is built on each component's individual evidence base, plus clinical observation.

A follow-up tissue study from Marquardt et al. (2025) showed that the thermal coagulation zones created by Ultherapy are progressively replaced by elastic fiber regeneration over a period of 2 weeks to 3 months post-treatment — providing some histological support for the device's mechanism of action, even if the combination protocol itself has not been tested in a controlled trial.

Side Effects and What the Data Actually Says

It's worth being straightforward about adverse events. In the Ultherapy FDA trial (n=70), 7 adverse events were reported in total, with only 3 directly attributed to the procedure — all classified as mild skin welting (urticaria-like reactions) that resolved without sequelae. More commonly reported in real-world clinical settings are temporary redness, mild swelling, transient nerve sensations, and post-procedure tenderness — most of which settle within a few days.

Sofwave, by virtue of its shallower penetration depth, carries a lower inherent risk profile compared to deep-energy devices. However, 'fewer side effects' does not mean 'no reaction at all.' Temporary redness and mild tingling are within the expected normal response range and should be anticipated.

There is also a critical point about how to interpret the data in this article: the improvement rates cited for Ultherapy (73%, 67%) come from a submental and neck cohort — they may not directly translate to cheek, brow, or forehead outcomes. The Sofwave improvement rates (86%, 88%, 72%) are monotherapy figures and should not be assumed to remain identical when combined with other devices. Patient satisfaction across lifting studies generally ranges from 60–80%, with notable variability depending on baseline expectations and outcome measurement methods.

Reported Outcomes by Device (Individual Trial Data)

💡 No lifting device guarantees a fixed percentage improvement for every patient. Results depend on skin thickness, degree of laxity, age, and individual healing response.

How to Actually Choose: It Starts With the Layer, Not the Device Name

The most important takeaway from all of this is that the same device can function very differently depending on what it's paired with — and choosing based on a device name alone misses the point entirely. Sofwave combined with Thermage FLX is a fundamentally different treatment from Sofwave combined with Ultherapy and PRF, even though 'Sofwave' appears in both.

A more useful approach is to start from the skin's actual needs: How thick is the dermis? Where exactly is the laxity located — in the surface texture, the mid-face volume, or the deep fascial structure? What is the patient's age and healing capacity? These questions determine which layer needs to be addressed, and the device combination follows from that assessment — not the other way around.

At MAGMA CLINIC, the protocol design process starts with skin thickness assessment, laxity mapping, and a layered treatment plan — rather than defaulting to a preset combination. Individual results will always vary, and no combination can be promised to deliver a specific percentage improvement. But matching the energy depth to the actual anatomical problem is a more evidence-consistent approach than selecting devices based on brand recognition alone.

Frequently Asked Questions

Can I combine Sofwave and Ultherapy in the same session?

Combining Sofwave and Ultherapy in a single session is technically feasible because the two devices target different depths — Sofwave at the mid-dermis (~1.5 mm) and Ultherapy at the SMAS layer (~4.5 mm). However, whether this combination is appropriate for you depends on your current skin condition, laxity level, and recovery capacity. There is no large-scale controlled study directly comparing combination protocols to monotherapy, so outcomes can vary. A direct assessment is recommended before deciding on any layered approach.

How painful is Ultherapy compared to Sofwave?

Ultherapy is generally reported as more uncomfortable than Sofwave, largely because it delivers concentrated focal energy to a deeper fascial layer. Most patients describe it as a warming or sharp prickling sensation during the pulse delivery. Sofwave tends to produce milder sensations due to its shallower target depth and broader heat distribution. Pain tolerance varies significantly between individuals, and topical anesthesia or other comfort measures may be discussed at your clinic depending on your sensitivity.

How many sessions of Sofwave or Ultherapy are typically needed?

Many clinical protocols use a single session as the baseline treatment, with reassessment at 3–6 months to determine whether a repeat session would be beneficial. Some patients find a single annual session sufficient for maintenance, while others may benefit from additional sessions depending on their skin aging progression. Because individual response varies — based on skin thickness, baseline laxity, and lifestyle factors — the frequency should be decided on a case-by-case basis rather than a fixed schedule.

Is Thermage FLX the same type of device as Sofwave and Ultherapy?

No — Thermage FLX uses radiofrequency (RF) energy, while Sofwave and Ultherapy both use ultrasound. RF and ultrasound interact with tissue differently: Thermage heats a broad dermal volume through electrical resistance, while ultrasound devices focus acoustic energy at targeted depths. In clinical practice, RF and ultrasound devices are sometimes combined because their mechanisms are complementary rather than redundant — but they are not interchangeable.

What is PRF and why is it sometimes added to a lifting protocol?

PRF stands for Platelet-Rich Fibrin — a concentrate derived from the patient's own blood that contains growth factors involved in tissue repair. When added to a lifting protocol that uses thermal energy devices like Ultherapy or Sofwave, the rationale is that these growth factors may support faster and smoother recovery of the tissue that has been thermally stimulated. This is based on the individual mechanisms of PRF and thermal devices; a direct controlled study specifically evaluating the triple combination of Sofwave + Ultherapy + PRF has not yet been published.